Terns Pharma Stock (NASDAQ: TERN) stock price, news, charts, stock research, profile.
You can purchase shares of Terns Pharma (NASDAQ:TERN) through any online brokerage.
Other companies in Terns Pharma’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
Terns Pharma has a consensus price target of $16.25.
The stock price for Terns Pharma (NASDAQ: TERN) is $7.27 last updated November 12, 2024 at 4:05 PM EST.
There are no upcoming dividends for Terns Pharma.
Terns Pharma’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Terns Pharma.
Terns Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.